Advertisement

Peritonitis

  • William F. Keane
  • Stephen I. Vas

Abstract

The frequent occurrence of peritonitis — one of the major complications of peritoneal dialysis — has hindered the development and acceptance of this technique.

Keywords

Peritoneal Dialysis Continuous Ambulatory Peritoneal Dialysis Peritoneal Dialysis Patient Exit Site Dialysis Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Seligman AM, Frank HA, Fine J. Treatment of experimental uremia by means of peritoneal irrigation. J Clin Invest 1946; 25: 211–9.CrossRefGoogle Scholar
  2. 2.
    Fine J, Frank HA, Seligman AM. The treatment of acute renal failure by peritoneal irrigation. Ann Surg 1946; 124: 857–78.CrossRefGoogle Scholar
  3. 3.
    Frank HA, Seligman AM, Fine J. Further experi ences with peritoneal irrigation for acute renal failure. Ann Surg 1948; 128: 561–608.CrossRefGoogle Scholar
  4. 4.
    Grollman A, Turner LB, McLean JA. Intermittent peritoneal lavage in nephrectomized dogs and its application to the human being. Arch Intern Med 1951; 87: 379–90.CrossRefGoogle Scholar
  5. 5.
    Doolan PD, Murphy WP, Wiggins RA, Carter NW, Cooper WC, Watten RH, Alpen EL. An evaluation of intermittent peritoneal lavage. Am J Med 1959; 26: 831–44.PubMedCrossRefGoogle Scholar
  6. 6.
    Weston RE, Roberts M. Clinical use of stylet-catheter for peritoneal dialysis. Arch Intern Med 1965; 115: 659–62.PubMedCrossRefGoogle Scholar
  7. 7.
    Maxwell MH, Rockney RE, Kleeman CR, Twiss MR. Peritoneal dialysis I. Technique and applications. JAMA 1929; 170: 917–24.CrossRefGoogle Scholar
  8. 8.
    Cohen SL, Percival A. Prolonged peritoneal dialysis in patients awaiting renal transplantation. Br Med J 1968; 1: 409–13.PubMedCrossRefGoogle Scholar
  9. 9.
    Leigh DA. Peritoneal infections in patients on long-term peritoneal dialysis before and after human cadaveric renal transplantation. J Clin Pathol 1969; 22: 539–44.PubMedCrossRefGoogle Scholar
  10. 10.
    Palmer RA, Quinton WE, Gray JE. Prolonged peritoneal dialysis for chronic renal failure. Lancet 1964; 1: 700–2.PubMedGoogle Scholar
  11. 11.
    Tenckhoff H, Schecter H. A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 1968; 14: 181–7.PubMedGoogle Scholar
  12. 12.
    Tenckhoff H, Curtis FK. Experience with maintenance peritoneal dialysis in the home. Trans Am Soc Artif Intern Organs 1970; 16: 90–5.PubMedGoogle Scholar
  13. 13.
    Brewer TE, Caldwell FT, Patterson RM, Flanigan WJ. Indwelling peritoneal (Tenckhoff) dialysis catheter. Experience with 24 patients. JAMA 1972; 219: 1011–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Lankisch PG, Tonnis HJ, Fernandez-Redo E, Girndt J, Kramer P, Quellhorst E, Scheller F. Use of Tenckhoff catheter for peritoneal dialysis in terminal renal failure. Br Med J 1973. 4: 712–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Palmer RA. Peritoneal dialysis by indwelling catheter for chronic renal failure 1963–1968. Can Med Assoc J 1971; 105: 376–80.PubMedGoogle Scholar
  16. 16.
    Rae A, Pendray M. Advantages of peritoneal dialysis in chronic renal failure. JAMA 1973, 225: 937–41.PubMedCrossRefGoogle Scholar
  17. 17.
    Devine H, Oreopoulos DG, Izatt S, Mathews R, deVeber GA. The permanent Tenckhoff catheter for chronic peritoneal dialysis. Can Med Assoc J 1975; 113: 219–21.PubMedGoogle Scholar
  18. 18.
    Petrie JJB, Jones EOP, Hartley LCJ, Olife KP, Clunie CJA. The use of an indwelling peritoneal catheter in the treatment of chronic renal failure. Med J Aust 1976; 2: 119–22.PubMedGoogle Scholar
  19. 19.
    Popovich RP, Moncrief JW, Decherd JB, Bomar JB, Pyle WK. The definition of a novel portable/wearable equilibrium peritoneal dialysis technique (abstract). Abstr Am Soc Artif Intern Organs 1976; 5: 64–8.Google Scholar
  20. 20.
    Popovich RP, Moncrief JW, Nolph KD, Ghods AJ, Twardowski ZJ, Pyle WK. Continuous ambulatory peritoneal dialysis. Ann Intern Med 1978; 88: 449–56.PubMedGoogle Scholar
  21. 21.
    Oreopoulos DG, Robson M, Izatt S, Clayton S, deVeber GA. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978; 24: 484–7.PubMedGoogle Scholar
  22. 22.
    Rubin J, Rodgers WA, Taylor HM, Everett ED, Prowant BF, Fruto LU, Nolph KD. Peritonitis during continuous ambulatory dialysis. Ann Intern Med 1980; 92: 7–13.PubMedGoogle Scholar
  23. 23.
    Oreopoulos DG. Continuous ambulatory peritoneal dialysis in Canada. Can Med Assoc J 1979; 120: 16–9.PubMedGoogle Scholar
  24. 24.
    Oreopoulos DG, Clayton S, Dombros N, Zellerman G, Katirtzoglou A. Experience with continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 25: 95–7.Google Scholar
  25. 25.
    Fenton SSA, Cattran DC, Ahlen AF, Rutledge P, Ampil M, Dadson J, Locking H, Smith D, Wilson DR. Initial experiences with continuous ambulatory peritoneal dialysis. Artif Organs 1979; 3: 206–9.PubMedCrossRefGoogle Scholar
  26. 26.
    Oreopoulos DG, Khanna R, McCready W, Katirtzoglou A, Vas S. Continuous ambulatory peritoneal dialysis in Canada. Dial Transpl 1980; 9: 224–6.Google Scholar
  27. 27.
    Blagg CR, Scribner BH. Long-term dialysis; current problems and future prospects. Am J Med 1980; 68: 633–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Peritoneal dialysis in chronic renal failure (editorial). Lancet 1978; 2: 303.Google Scholar
  29. 29.
    Moncrief JW. Continuous ambulatory peritoneal dialysis. Dial Transpl 1979; 8: 1077–8.Google Scholar
  30. 30.
    Home peritoneal dialysis for end-stage renal disease. Med Lett Drugs Ther 21: 69–70.Google Scholar
  31. 31.
    National CAPD Registry of the NIH (1987). Characteristics of participants and selected outcome measures for the period January 1, 1981 through August 31 1986.Google Scholar
  32. 32.
    Diaz-Buxo JA, Walker PJ, Farmes CD, Chandler JT, Holt KL. Continuous cyclic peritoneal dialysis -The Nalle Clinic experience. In: Price JDE (ed), Peritoneal Dialysis. The State of the Art. Communication Media for Education, Princeton, NY 1983; pp 23–5.Google Scholar
  33. 33.
    Hau T, Ahrenholz DH, Simmons RL Secondary bacterial peritonitis: The biologic basis of treatment. In: Current problems in Surgery. Vol 16 No. 10 Year Book Medical Publ Inc Chicago 1979.Google Scholar
  34. 34.
    Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Med Clin North Am 1975; 59: 963–81.PubMedGoogle Scholar
  35. 35.
    Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Balt) 1971; 50: 161–97.CrossRefGoogle Scholar
  36. 36.
    Bar-Meir S, Conn HO. Spontaneous bacterial peritonitis induced by intraarterial vasopressin therapy. Gastroenterology 1976; 70: 418–21.PubMedGoogle Scholar
  37. 37.
    Conn HO. Bacterial peritonitis: spontaneous or paracentric? (editorial). Gastroenterology 1979; 77: 1145–6.PubMedGoogle Scholar
  38. 38.
    Targan SR, Chow AW, Guze LB. Role of anaerobic bacteria in spontaneous peritonitis of cirrhosis. Report of two cases and review of the literature. Am J Med 1977; 62: 397–403.PubMedCrossRefGoogle Scholar
  39. 39.
    Stephen CG, Meadows JG, Kerkering TM, Markowitz SW, Nisman RM. Spontaneous peritonitis due to Hemophilus influenzae in an adult. Gastroeinterology 1979; 77: 1088–90.Google Scholar
  40. 40.
    Hau T, Hoffman R, Simmons RL. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis. Surgery 1978; 83: 223–9.PubMedGoogle Scholar
  41. 41.
    Stewart WK, Anderson DC, Wilson MI. Hazard of peritoneal dialysis: contaminated fluid. Br Med J 1967; 1: 606–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Helfrick GB, Pechau BW, Alijani MR, Barnard WF, Rakowski TA, Winchester JF. Reduction of catheter complications with lateral placement. Perit Dial Bull 1983; 4 (suppl 3): 2–4.Google Scholar
  43. 43.
    Schweinburg FB, Seligman AM, Fine J. Transmural migration of intestinal bacteria. A study based on the use of radioactive Escherichia coli. N Engl J Med 1950; 242: 747–51.PubMedCrossRefGoogle Scholar
  44. 44.
    Wu G, Khanna R, Vas S, Oreopoulos DG. Is extensive diverticulosis of the colon a contraindication to CAPD. Perit Dial Bull 1983; 3: 180–3.Google Scholar
  45. 45.
    Singh MM, Bhargawa AN, Jain KB. Tuberculous peritonitis: An evaluation of pathogenic mechanisms, diagnostic procedures and therapeutic measures. New Eng J Med 1969; 281: 1091–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Khanna R, Oreopoulos DG, Vas SI, McCready W, Dombros N. Fungal peritonitis in patients undergoing chronic intermittent or continuous peritoneal dialysis. Proc EDTA 1980; 17: 291–6.Google Scholar
  47. 47.
    Coward RA, Gokal R, Mallick NP. Recurrent peritonitis associated with vaginal leak. Perit Dial Bull 1983; 3: 164–5.Google Scholar
  48. 48.
    Dias-Buxo JA, Burgess P, Walker PJ. Peritoneovaginal fistula-unusual complication of peritoneal dialysis. Perit Dial Bull 1983; 3: 142–3.Google Scholar
  49. 49.
    Abrutyn E, Goodhart GL, Roos K, Anderson R, Buxton A. Acinetobacter calcoaceticus outbreak associated with peritoneal dialysis. Am J Epidemiol 107: 328–35.Google Scholar
  50. 50.
    Mader JT, Reinarz JA. Peritonitis during peritoneal dialysis. the role of the preheating water bath. J Chron Dis 1978; 31: 635–64.PubMedCrossRefGoogle Scholar
  51. 51.
    Baud JD, Ward J, Fraser DW, Peteroon NJ, Silcox VA, Good RC, Ostroy PR, Kennedy J. Peritonitis due to a mycobacterium chelonei like organism associated with intermittent chronic peritoneal dialysis. J Inf Dis 1982; 145: 9–17.CrossRefGoogle Scholar
  52. 52.
    Poisson M, Beromicide V, Falardeau C, Vega C, Morisset R. Mycobacterium chelonei peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1983; 3: 86–8.Google Scholar
  53. 53.
    Majno G, Palade GE. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Cytol 1961; 11: 571–600.PubMedCrossRefGoogle Scholar
  54. 54.
    Ellis H. The cause and prevention of post-operative intraperitoneal adhesions. Surg Gynecol Obstet 1971; 133: 497–511.PubMedGoogle Scholar
  55. 55.
    Myhre-Jensen O, Larsen SB, Astrup T. Fibrinolytic activity in serosal and synovial membrane. Arch Pathol 1969; 88: 623–57.Google Scholar
  56. 56.
    Porter JM, McGregor FH, Mullen DC, Silver D. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 80–2.PubMedGoogle Scholar
  57. 57.
    Ellis H. The aetiology of post-operative abdominal adhesions. An experimental study. Br J Surg 1962; 50: 10–6.PubMedCrossRefGoogle Scholar
  58. 58.
    Buckman RF, Woods M, Sargent L, Gervin AS. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976; 20: 1–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Gervain AS, Puckett CL, Silver D. Serosal hypofibrinolysis. A cause of post-operative adhesions. Am J Surg 1973; 125: 80–8.CrossRefGoogle Scholar
  60. 60.
    Hau T, Payne WD, Simmons RL. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979; 148: 415–8.PubMedGoogle Scholar
  61. 61.
    Weinstein MP, Iannini PB, Stratton CW, Eickhoff TL. Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med 1978; 64: 592–8.PubMedCrossRefGoogle Scholar
  62. 62.
    Gilmour J, Tymiansky R, Pierratos A, Vas S, Klein M, Khanna R, Digenis D, Cuff S, Oreopoulos DG. Changes in some inflammatory proteins during peritonitis in CApd patients. Perit Dial Bull 1983; 3: 201–4.Google Scholar
  63. 63.
    Verbough HA, Keane WF, Hoidal JR, Freiberg MR, Elliott GR, Peterson PK. Peritoneal macrophages and opsonins: Antibacterial defense in patients undergoing chronic peritoneal dialysis. J Inf Dis 1983; 147: 1018–29.CrossRefGoogle Scholar
  64. 64.
    Duwe A, Vas SI, Weatherhead JWS. Effect of composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infec Immun 1981; 33: 130–5.Google Scholar
  65. 65.
    Collart F, Tielemaus C, Schandene L, Dupont E, Wybrau Y, Dratwe M. CAPD and cellular immunity: No different than hemodialysis patients. Perit Dial Bull 1983; 3: 163–4.Google Scholar
  66. 66.
    Giaccino F, Alloatti S, Guarello F, Coppo R, Pellerey M, Piccoli G. The influence of peritoneal dialysis on cellular immunity. Perit Dial Bull 1982; 2: 165–8.Google Scholar
  67. 67.
    Vas SI, Low DE, Layne S, Khanna R, Dombros N. Microbiological diagnostic approach to peritonitis in CAPD patients (1981). In: Atkins RC et al. (ed), peritoneal Dialysis. Churchill Livingstone, Edinburgh 1981; pp 269–71.Google Scholar
  68. 68.
    Vas SI. Peritoneal fluid cultures remain positive for days. Perit Dial Bull 1982; 2: 144.Google Scholar
  69. 69.
    Swartz RD, Campbell DA, Stone D, Dickinson C. Recurrent polymicrobial peritonitis from a gynecological source as a complication of CAPD. Perit Dial Bull 1983; 3: 32–3.Google Scholar
  70. 70.
    Vas SI. Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney International 1983; 23: 83–92.PubMedCrossRefGoogle Scholar
  71. 71.
    Dobbelstein H. Immune system in uremia. Nephron 1976; 17: 409–14.PubMedCrossRefGoogle Scholar
  72. 72.
    Montgomery YZ, Kalmanson GR, Guze LB. Renal failure and infection. Medicine 1968; 47: 1–32.Google Scholar
  73. 73.
    Vas SI. Peritonitis during CAPD. A mixed bag. Perit Dial Bull 1981; 1: 47–9.Google Scholar
  74. 74.
    Nichols WK, Nolph KD. A technique for managing exit site and cuff infection in Tenckhoff catheters. Perit Dial Bull 1983; 3 (suppl): S4–5.Google Scholar
  75. 75.
    Khanna R, McNeely DJ, Oreopoulos DG, Vas SI, McCready W. Treating fungal infections: fungal peritonitis in CAPD. Br Med J 1980; 280: 1147–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Kloos WE, Schleifer HK. Simplified scheme for the routine identification of human staphylococcus species. J Clin Microbio 1975; 1: 82–8.Google Scholar
  77. 77.
    Peter G, Locci R, Pulverer G. Adherence and growth of coagulase negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982; 146: 479–82.CrossRefGoogle Scholar
  78. 78.
    Gregory MC, Duffy DP. Toxic shock following staphylococcal peritonitis. Clin Nephrol 1983; 20: 101–4.PubMedGoogle Scholar
  79. 79.
    Facklam RR. Physiological differentiation of viridans streptococci. J Clin Microbiol 1977; 5: 184–201.PubMedGoogle Scholar
  80. 80.
    Pierard D, Lauwers S, Monton MC, Sennesael J, Verbeelen D. Group JK Corynebacterium peritonitis in a patient undergoing continuyous ambulatory peritoneal dialysis. J Clin Microbiol 1983; 18: 1011–4.PubMedGoogle Scholar
  81. 81.
    Arfania D, Everett ED, Nolph K, Rubin J. Uncommon causes of peritonitis in patients undergoing peritoneal dialysis. Arch Int Med 1981; 141: 61–64.CrossRefGoogle Scholar
  82. 82.
    Kolmos HJ, Anderson KEH. Peritonitis with Pseudomonas aeruginosa in hospitalized patients treated with peritoneal dialysis. Scand J Infect Dis 1979; 11: 207–10.PubMedGoogle Scholar
  83. 83.
    Matthews P. Primary anaerobic peritonitis. Br Med J 1979; 2: 903–4.PubMedCrossRefGoogle Scholar
  84. 84.
    Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL Microbial synergy in experimental intra-abdominal abscess. Infect Immun 13: 22–6.Google Scholar
  85. 85.
    Simkin EP, Wright FK. Perforating injuries of the bowel complicating peritoneal catheter insertion. Lancet 1968; 1: 64–6.PubMedCrossRefGoogle Scholar
  86. 86.
    Rubin J, Oreopoulos DG, Lio TT, Mathews R, deVeber GA. Management of peritonitis and bowel perforation during chronic peritoneal dialysis. Nephron 1976; 220–5.Google Scholar
  87. 87.
    Wu G. Review of peritonitis episodes that caused interruption of CAPD. Perit Dial Bull 1983; 3 (suppl): S11–3.Google Scholar
  88. 88.
    Sasaki S, Aliba T, Suenaga M, Tornura S, Yoobiyama N, Nakagawa S, Shoji T, Sasavka T, Takenchi J. Ten years survey of dialysis associated tuberculosis. Nephron 1979; 24: 141–5.PubMedCrossRefGoogle Scholar
  89. 89.
    O’Connor J, MacCormick M. Tuberculous peritonitis in patients on CAPD: The importance of lymphocytosis in the peritoneal fluid. Perit Dial Bull 1: 106.Google Scholar
  90. 90.
    Morford DW. High index of suspicion for tuberculous peritonitis in CAPD patients. Perit Dial Bull 1982; 2: 189–90.Google Scholar
  91. 91.
    Dineen P, Hornan WP, Grafe WP. Tuberculous peritonitis: 43 years experience in diagnosis and treatment. Am Surg 1976; 184: 712–7.Google Scholar
  92. 92.
    Wolfe JHN, Behn AR, Jackson BT. Tuberculous peritonitis and role of diagnostic laparoscopy. Lancet 1978: Lancet 1: 852–853.Google Scholar
  93. 93.
    Vas SI Editorial comment. Perit Dial Bull 1982; 2: 190.Google Scholar
  94. 94.
    Bayer AS, Blumenkrantz MY, Montgomerie JZ, Galpin JE, Coburn JW, Gruze LB. Candida peritonitis. Am J Med 1976; 61: 832–40.PubMedCrossRefGoogle Scholar
  95. 95.
    Kerr CM, Perfect JR, Craven PC, Jorgensen JH, Drutz DJ, Shelburne JD, Gallis HA, Gutman RA. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Int Med 1983; 99: 334–7.PubMedGoogle Scholar
  96. 96.
    Holdsworth SR, Atkins RC, Scott DF, Jackson R. Management of Candida peritonitis by prolonged peritoneal lavage containing 5-fluorocytosine. Clin Nephrol 1975; 4: 157–9.PubMedGoogle Scholar
  97. 97.
    Lempert KD, Jones JM. Flucytosine -miconazole treatment of Candida peritonitis: Its use during continuous ambulatory peritoneal dialysis. Arch Int Med 1982; 142: 577–8.CrossRefGoogle Scholar
  98. 98.
    Chapman JR, Warnoch DW. Ketoconazole and fungal CAPD peritonitis. Lancet II: 1983; 510–1.CrossRefGoogle Scholar
  99. 99.
    Pearson JG, McKinney TD, Stone WJ. Penicillium peritonitis in a CAPD patient. Perit Dial Bull 1983; 3: 20–1.Google Scholar
  100. 100.
    NIH CAPD Patient Registry Report. 1987; Characteristics of participants and selected outcome measures for the period January 1 1981 through August 31 1986.Google Scholar
  101. 101.
    Steiner R. Clinical observations on the phathogenesis of peritoneal dialysate eosinophilia. Perit Dial Bull 1982; 2: 118–9.Google Scholar
  102. 102.
    Verger C, Berry JP, Galle P, Pavergue A, Hoang C, LeCharpentier Y. Foreign material inclusions in the peritoneum of CAPD patients: a study with X-ray microanalysis. Perit Dial Bull 1982; 2: 138–9.Google Scholar
  103. 103.
    Williams P, Khanna R, Simipson H, Vas SI. Tobramycin blood levels of CAPD patients during peritonitis. Perit Dial Bull 1982; 2: 48.Google Scholar
  104. 104.
    Manuel MA, Paton TW, Cornish WR. Drugs and peritoneal dialysis. Perit Dial Bull 1983; 3: 117–25.Google Scholar
  105. 105.
    Sewell DL, Golper TA. Stability of antimicrobial agents in peritoneal dialysate. Antimicrob Agents Chemother 21: 528–9.Google Scholar
  106. 106.
    Sewell DL, Golper TA, Brown SD, Nelson E, Knower M, Kimbrough RC. Stability of single and combination antimicrobial agents in various peritoneal dialysates in the presence of insulin and heparin. Am J Kidney Dis 1983; 3: 209–12.PubMedGoogle Scholar
  107. 107.
    Rubin J, Jumphries J, Smith G, Bower J. Antibiotic activity in peritoneal dialysate. Am J Kidney Dis 1983; 3: 205–8.PubMedGoogle Scholar
  108. 108.
    Bunke CM, Aronoff GR, Luft C. Pharmacokinetics of common antibiotics used in continuous ambulatory peritoneal dialysis. Amer J Kidney Dis 1983; 3: 114–7.Google Scholar
  109. 109.
    Vas SI. Letter. Perit Dial Bull 1981; 1: 67.Google Scholar
  110. 110.
    Gokal R, Vas SI. Risk of tobramycin use in CAPD patients with peritonitis. Perit Dial Bull 1982: 2: 139–41.Google Scholar
  111. 111.
    Silva J, Fekety R. Clostridia and antimicrobial enterocolitis. Am Rev Med 1981; 32: 327–33.CrossRefGoogle Scholar
  112. 112.
    Antibiotic lavage for peritonitis. Editorial (1979) Brit Med Jour Sept 22, 1979; pp 691–2.Google Scholar
  113. 113.
    Stephen RL. Kablitz C, Kitahara M, Welson JA, Duffin DP, Kolff WJ. Peritoneal dialysis: peritonitis: saline iodine flush. Dial Transpl 1979; 8: 584–95.Google Scholar
  114. 114.
    Nolph KD. In: Continuous Ambulatory Peritoneal Dialysis, ed. by Legrain M. Excerpta Medica, New York, 1980; p 272.Google Scholar
  115. 115.
    Digenis GE, Khana R, Pierratos A, Vas S. Morbidity and mortality after treatment of peritonitis with prolonged exchanges and intraperitoneal antibiotics. Perit Dial Bull 1982; 2: 45–6.Google Scholar
  116. 116.
    Cantaluppi A, Scalamogna A, Guerra L, Graziani G, Ponticelli C. Treatment of peritonitis in patients on CAPD. Perit Dial Bull 1982; 2: 142.Google Scholar
  117. 117.
    DeGroc F, Rottembourg J, Jacq D, Jaslier V, N’Guyen J, Legrain M. Les peritonites au cours de la dialyse peritoneal continue ambulatoire. Traitment par lavage ou non? Etude prospective. Nephrologie (SWZ) 1983; 4: 24–7.Google Scholar
  118. 118.
    De Tremont JF, Khissi H, Thomas D, Tolain M, Lawrence G, Coevoet B, Fournier A, Orfica J. Traitment des peritonites ou dialyse peritoneal. Comparison entre lavage continue avec machine et lavage intermittent par quatre sac/jour de DPCA. Pathol Biol (Paris) 1983; 31: 544–7.Google Scholar
  119. 119.
    Helfrich GB, Winchester JF. Shaving of external cuff or peritoneal catheter. Perit Dial Bull 1982; 2: 183.Google Scholar
  120. 120.
    Digenis GE, Khanna R, Pantalony D. Eosinophilia after implantation of the peritoneal catheter. Perit Dial Bull 1982; 2: 98–9.Google Scholar
  121. 121.
    Vas SI. Indications for removal of peritoneal catheter. Perit Dial Bull 1981; 1: 145–6.Google Scholar
  122. 122.
    Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwantsuki S, Geis WP, Hano JE. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients Arch Int Med 1980; 140: 1201–3.CrossRefGoogle Scholar
  123. 123.
    Schmidt RW, Blumenkrantz M. Peritoneal sclerosis. A sword of Democles for peritoneal dialysis. Arch Int Med 141: 1265–7.Google Scholar
  124. 124.
    Sclerosing Peritonitis, Letters to the editor (1983) Lancet July 9 August 13, September 3, September 24, November 5, 1983.Google Scholar
  125. 125.
    Fenton SSA. Peritonitis related deaths among CAPD patients. Perit Dial Bull 1983; 3 (suppl 3): S9–11.Google Scholar
  126. 126.
    Wu G. Cardiovascular deaths among CAPD patients. Perit Dial Bull 1983; 3 (suppl 3): S23–6.Google Scholar
  127. 127.
    Oreopoulos D, Vas S, Khanna R. Prevention of peritonitis during continuous ambulatory peritoneal dialysis. Perit Dial Bull 1983; 3 (suppl 3): S18–20.Google Scholar
  128. 128.
    Hamilton RW, Disher BA, Dillingham GA, Nicholas AF. The sterile weld a new method for connection in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1983; 2 (suppl 4): S8–10.Google Scholar
  129. 129.
    Buonchristiani U, Cozzari M, Quintiliani G, Carobi C. Abatement of exogenous peritonitis using the Perugia CAPD system. Dial Transplant 1983; 12: 14–25.Google Scholar
  130. 130.
    Ash SR, Hoswell R, Heefer EM, Bloch R. Effect of the Peridex filter on peritonitis rates in a CAPD population. Perit Dial Bull 1983; 3: 89–93.Google Scholar
  131. 131.
    Eremin J, Marshall VC. The place of prophylactic antibiotic in peritoneal dialysis. Aust Ann Med 1969; 18: 264–6.PubMedGoogle Scholar
  132. 132.
    Sharma BK, Smith EC, Rodriguez H, Pillay UKG, Gandhi VC, Dunea G. Trial of oral neomycin during peritoneal dialysis. Am J Med Sei 1971; 262: 175–8.CrossRefGoogle Scholar
  133. 133.
    Axelrod J, Meyers BR, Hirschman SZ, Stein R. Prophylaxis with cephalothin in peritoneal dialysis. Arch Intern 1973; 132: 368–71.CrossRefGoogle Scholar
  134. 134.
    Low DE, Vas SI, Oreopoulos DG, Manuel RA, Saiphoo CS, Finer C, Dombros N. Randomized Clinical trial of prophylactic cephalexin in CAPD. Lancet 1980; 2: 753–4.PubMedCrossRefGoogle Scholar
  135. 135.
    Corey PN, Steele C. Risk factors associated with time to first infection and time to failure on CAPD. Perit Dial Bull 1983; 3 (suppl 3): S14–7.Google Scholar
  136. 136.
    D’Apice AJF, Atkins RC. Analysis of peritoneal dialysis data. Peritoneal Dialysis Edited: Atkins RC, Thomas NM, Farrell PC, Churchill Livingstone, Edinburge, pp 440–4.Google Scholar
  137. 137.
    Randerson DH, Farrell PC. Analysis of peritonitis data in CAPD 2nd Int. Symposium in Peritoneal Dialysis, Berlin, 1981; p 52.Google Scholar
  138. 138.
    Corey P. An approach to the statistical analysis of peritonitis data from patients on CAPD. Perit Dial Bull 1981; Suppl Vol 1 No 6: S29–32.Google Scholar
  139. 139.
    Pierratos A, Amair P, Corey P, Vas SI, Khanna R, Oreopoulos DG. Statistical analysis of the incidence of peritonitis in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1982; 2: 32–6.Google Scholar
  140. 140.
    Ryan GB, Grobety J, Majno G. Post-operative peritoneal adhesions. A study of the mechanisms. Am J Pathol 65: 1971; 117: 117–38.PubMedGoogle Scholar
  141. 141.
    Mion CM, Boen ST, Scribner P. Analysis of factors responsible for the formation of adhesions during chronic peritoneal dialysis. Am J Med Sci 1965; 250: 675–9.PubMedCrossRefGoogle Scholar
  142. 142.
    Steiner RW, Kipper S, Savoia MC, Witztum KF. Identification of peritoneal dialysis catheter tunnel infection by scanning with Indium-111 labelled leukocytes. Ann Int Med 1983; 99: 44–5.PubMedGoogle Scholar
  143. 143.
    Williams P, Pantalony D, Vas SI, Khanna R, Oreopoulos DG. The value of dialysate cell count in the diagnosis of peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit Dial Bull 1981; 1: 59–62.Google Scholar
  144. 144.
    Kapral FA, Godwin JR, Dye ES. Formation of intraperitoneal abscesses by Staphylococcus aureus. Infec Immun 1980; 30: 204–11.Google Scholar
  145. 145.
    Karanicolas S, Oreopoulos DG, Frath Sh, Shiminer A, Manning RF Sepp H, de Veber GA, Darby T. Epidemic of aseptic peritonitis caused by endotoxin during chronic peritoneal dialysis. N Engl J Med 1972; 296: 1336–7.CrossRefGoogle Scholar
  146. 146.
    Williams P, Khanna R, Vas S, Layne S, Pantalony D, Oreopoulos DG. Treatment of peritonitis in patients on CAPD: To lavage or not. Perit Dial Bull 1980: 1: 14–7.Google Scholar
  147. 147.
    O’Leary JP, Malik FS, Donahoe RR, Johnston AD. The effects of a minidose of heparin on peritonitis in rats. Surg Gynecol Obstet 1979; 148: 571–5.PubMedGoogle Scholar
  148. 148.
    Cotran RS, Karnowsky MJ. Ultrastructural Studies on the permeability of the mesothelium to horse radish peroxidase. J Cell Biol 1968; 37: 123–37.PubMedCrossRefGoogle Scholar
  149. 149.
    MacCallum WG. On the mechanism of absorption of granular materials from the peritoneum. Bull Johns Hopkins Hosp 1903; 14: 105–10.Google Scholar
  150. 150.
    Casley-Smith JR. An electron microscopical study of the passage of ions through the endothelium of lymphatic and blood capillaries, and through the mesothelium. Quart J Exp Physiol 1967; 52: 105–13.PubMedGoogle Scholar
  151. 151.
    Courtice FC, Simmonds WJ. Physiological significance of lymph drainage of the serous cavities and lungs. Physiol Rev 1954; 34: 419–49.PubMedGoogle Scholar
  152. 152.
    Lorber B, Swenson RM, The bacteriology of intraabdominal infections. Surg Clin North Am 1975; 55: 1349–54.PubMedGoogle Scholar
  153. 153.
    McNeely D, Vas SI, Dombros N, Oreopoulos DG. Fusarium peritonitis: an uncommon complication. Perit Dial Bull 1981; 1: 94–6.Google Scholar
  154. 154.
    Marrie TJ, Noble MA, Costerton JW. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. Jour Clin Microbiol 1983; 18: 1388–98.Google Scholar
  155. 155.
    Vas, SI and Low L. Microbiological diagnosis of peritonitis in patients on continuous ambulatory peritonei dailysis. J Clin Microb 1985; 21: 522–3.Google Scholar
  156. 156.
    Rubin SJ. Continuous ambulatory peritoneal dialysis: Dialysate fluid cultures. Clin Microbiol Newsl 1984; 6: 3–5.CrossRefGoogle Scholar
  157. 157.
    Fenton P. Laboratory diagnosis in patients undergoing continuous ambulatory peritoneal dialysis. J Clin Path 1982; 35: 1181–4.PubMedCrossRefGoogle Scholar
  158. 158.
    Knight KR, Rolak A, Crump J Maskell R. Laboratory diagnosis and oral treatment of CAPD patients. Lancet 1982; 2: 1301–4.PubMedCrossRefGoogle Scholar
  159. 159.
    Buggy BP. Culture methods for continuous ambulatory peritoneal dialysis associated peritonitis. Clin Microb Newsletter 1986; 8: 12–4.CrossRefGoogle Scholar
  160. 160.
    Smalley DL, Baddour LM, Kraus AP. Rapid detection of Gram-negative bacterial peritonitis by the Limulus amoebocyte lysate assay. J Clin Microbiol 1986; 24: 882–3.PubMedGoogle Scholar
  161. 161.
    Clayman MD, Raymond A, Colen D, Moffit C, Wolf C, Neilson E. The Limulus amebocyte lysate assay. Arch Int Med 1987; 147: 337–40.CrossRefGoogle Scholar
  162. 162.
    Oreopoulos DG, Vas SI. Peritonitis in continous ambulatory peritoneal dialysis: Making therapeutic decisions easier. Arch Int Med 1987; 147: 818–9.CrossRefGoogle Scholar
  163. 163.
    Heering PJ, Bach D, Henzler P, Grabensee B, Dialysis and HIV infection. Nephron 1987; 47: 158–159.PubMedCrossRefGoogle Scholar
  164. 164.
    Berlyne GM, Rubin J, Adler AJ. Dialysis in AIDS patients. Nephron 1987; 44: 265–6.CrossRefGoogle Scholar
  165. 165.
    Robles R, Lopox-Gomez Jm, Muino A, Valderrabano F. Dialysis in AIDS Patients: A new problem. Nephron 1987; 44: 375–6.CrossRefGoogle Scholar
  166. 166.
    DeRossi A, Vertoli U, Romagnoli G, Bertoli M,Dalla Grassa O, Chieco-Bianchi L, LAV/HTL V-III and HTLV-I antibodies in hemodialysis patients. Nephron 1987; 44: 377–8.CrossRefGoogle Scholar
  167. 167.
    Morrison AJ, Freer CV, Poole CL, JOHNSTON DO, Westervelt F, Normansell DE, Wenzel RP. Prevalence of human lymphotropic virus type III antibodies among patients in dialysis programs at a university hospital. Ann Int Med 1986; 104: 805–7.PubMedGoogle Scholar
  168. 168.
    Humphreys MH, Scoenfield PY, Aids and renal disease. The Kidney 1987; 20: 7–12.Google Scholar
  169. 169.
    Rubin RH, Jenkins RL, Shaw BW, Shaffer D, Pearl RH, Erb S, Monaco AP, VanThiel DH. The aquired immunodeficiency syndrome and transplantation. Transplantation 1987; 44: 1–4.PubMedCrossRefGoogle Scholar
  170. 170.
    Olivera DBG, Winearls CG, Cohen J, Ind PW, Williams G. Severe immunosuppression in a renal transplant recipient with HTLV-III antibodies. Transplantation 1986; 41: 260–2.CrossRefGoogle Scholar
  171. 171.
    Favero MS. Recommended precautions for patients undergoing hemodialysis who have AIDS or non-A non-B hepatitis. Infection Control 1985; 6: 301–5.PubMedGoogle Scholar
  172. 172.
    Recommendations for providing dialysis treatment to patients infected with human T-Lymphotropic virus type III/lymphadenopathy-associated virus. MMWE 1986; 35: 376–83.Google Scholar
  173. 173.
    Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, Guttmann RD. Hepatitis B disease in dialysis and transplant patients. Transplantation 1987; 44: 369–76.PubMedCrossRefGoogle Scholar
  174. 174.
    Vas SI. Peritonitis of peritoneal dialysis patients: Pathogenesis and treatment. Medical Microbiology Vol 5: ed: Easmon CSF and Jeljaszewicz J. Academic Press London 1986; pp 21–63.Google Scholar
  175. 175.
    Gruer LD, Bartlett R, Aycliffe AJ. Species identification and antibiotic sensitivity of coagulase negative staphylococci from CAPD peritonitis. J Antimic Chemother 1984; 13: 577–83.CrossRefGoogle Scholar
  176. 176.
    Baddour LM, Smalley DL, Kraus AP, Lamoreaux WJ, Christensen GD. Comparison of microbiologic characteristics of pathogenic and saprophytic coagulase negative staphylococci from patients on continuous ambulatory peritoneal dialysis. Diagn Microbiol Infect Dis 1986; 5: 197–205.PubMedCrossRefGoogle Scholar
  177. 177.
    Horsman GB, Macmillan L, Amatnieks Y, Rifkin O, Vas SI. Plasmid profile and slime analysis of coagulase negative staphylococci from CAPD patients with peritonitis. Perit Dial Bull 1986; 6: 195–8.Google Scholar
  178. 178.
    Keane WF, Everett ED, Golper TA, Gokal R, Halstenson C, Kawaguchi Y, Riella M, Vas SI, Verbrugh HA. Peritoneal dialysis related peritonitis treatment recommendations: 1993 Update. The Ad Hoc advisory committee on peritonitis management. Perit Dial Intern 1993; 13: 14–28.Google Scholar
  179. 179.
    VI. Catheter related factors and peritonitis risk in CAPD patients. USRDS 1992 Annual Report. Am J Kidney Dis 20 (suppl. 2): 48–54.Google Scholar
  180. 180.
    Goldstein CS, Garrik RE, Polin RA, Gerdes JS, Kolski GB, Neilson EG, Douglas SD. Fibronectin and complement secration by monocytes and peritoneal macrophages in vitro from patients undergoing continuous ambulatory peritoneal dialysis. J Leucocyte Biol 1986; 39: 457–64.Google Scholar
  181. 181.
    Khan RH, Klein M, Vas S. Fibronectin in the normal peritoneal fluids of patients on chronic ambulatory peritoneal dialysis and during peritonitis. Perit Dial Bull 1987; 7: 69–73.Google Scholar
  182. 182.
    Holley J, Seibert D, Moss A. Peritonitis following colonoscopy and polypectomy: A need for prophylaxis? Perit Dial Bull 1987; 7: 105.Google Scholar
  183. 183.
    Stuck A, Seiler A, Frey FJ. Peritonitis due to an intrauterine contraceptive device in a patient on CAPD. Perit Dial Bull 1986; 7: 158–9.Google Scholar
  184. 184.
    Sombolos K, Vas S, Rifkin O, Ayomamitis A, McNamee P, Oreopoulos DG. Propionibacteria isolates and asymptomatic infections of the peritoneal effluent in CAPD patients. Nephrol Dial Transplant 1986; 1: 175–8.PubMedGoogle Scholar
  185. 185.
    Williams PS, Hendy MS, Ackrill P. Routine daily surveillance cultures in the management of CAPD patients. Peri Dial Bull 1987; 7: 183–6.Google Scholar
  186. 186.
    Gokal R, Ash S, Helfrich GB, Holme C, Joffe Pe, Nichols K, Oreopoulos DG, Riella M, Slingeneyer A, Twardowski ZJ, Vas SI. Peritoneal catheters and exit site practices: Toward optimum peritoneal access. Perit Dial Intern 1993; 13: 29–39.Google Scholar
  187. 187.
    Dasgupta MK, Bettcher KB, Ulan RA, Burns V, Lam K, Dossetor JB, Costerton JW. Relationship of adherent bacterial biofilms to peritonitis in chronic ambulatory peritoneal dialysis. Perit Dial Bull 1987; 7: 168–73.Google Scholar
  188. 188.
    Holmes CJ, Evans R. Biofilm and foreign body infection -The significance to CAPD associated peritonitis. Perit Dial Bull 1986; 6: 168–77.Google Scholar
  189. 189.
    Verger C, Chesneau AM, Thibault M, Bataille N. Biofilm on Tenckhoff catheters: A negligible source of contamination. Perit Dial Bull 1987; 6: 174–8.Google Scholar
  190. 190.
    Piraino B, Bernardini J, Peitzman A, Sorkin M. Failure of peritoneal cuff shaving to eradicate infection. Perit Dial Bull 1987; 7: 179–82.Google Scholar
  191. 191.
    Piraino B, Bernardini J, Johnston J, Sorkin M. Chemical peritonitis due to intraperitoneal vancomycin (Vancoled). Peri Dial Bull 1987; 7: 156–9.Google Scholar
  192. 192.
    Churchill DN, Oreopoulos DG, Taylor DW, Vas SI, Manuel MA, Wu G. Peritonitis in CAPD patients-A randomized clinical trial of trimethoprim-sulfamethoxazole prophylaxis. Abstr. 20th Ann Meeting of the American Societ of Nephrology, 1987; p 97A.Google Scholar
  193. 193.
    Harvey DM, Sheppard KJ, Morgan AG, Fletcher J. Effect of dialysate fluids on phagocytosis and killing by normal neutrophils. J Clin Microbiol 1987; 25: 1424–7.PubMedGoogle Scholar
  194. 194.
    McGregor SJ, Brock JH, Briggs JD, Junor BJ. Bactericidal activity of peritoneal macrophages from continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 1987; 2: 104–8.PubMedGoogle Scholar
  195. 195.
    Alobaidi HM, Coles GA, Davies M, Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1: 16–21.PubMedGoogle Scholar
  196. 196.
    Lewis SL, Van Epps DE. Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 1987; 9: 381–395.PubMedGoogle Scholar
  197. 197.
    Lamperi S, Carozzi S. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 219–25.PubMedCrossRefGoogle Scholar
  198. 198.
    Clark LA, Easmon CS. Opsonic activity of intravenous immunoglobulin preparations against Staphylococcus epidermidis. J Clin Pathol 1986; 39: 856–60.PubMedCrossRefGoogle Scholar
  199. 199.
    Clark LA, Easmon CS. Opsonic requirements of Staphylococcus epidermidis. J Med Microbiol 1986; 22: 1–7.PubMedCrossRefGoogle Scholar
  200. 200.
    Peterson PK, Lee D, Suh HJ, Devalon M, Nelson RD, Keane WF. Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis 1986; 7: 146–52.PubMedGoogle Scholar
  201. 201.
    Peterson PK, Gaziano E, Suh HJ, Devalon M, Peterson L, Keane WF, Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 49: 212–8.Google Scholar
  202. 202.
    Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 26: 733–40.Google Scholar
  203. 203.
    Wierusz-Wysocka B, Wysocki H, Michta G, Wykretowicz A, Czarnecki R, Baczyk K,. Phagocytosis and neutrophil bactericidal capacity in patients with uremia. Folia Haematol 1984; 111: 589–94.Google Scholar
  204. 204.
    Huttunen K, Lampainen E, Silvennoinen-Kassinen S, Tiilikainen A. The neutrophil function of uremic patients treated by hemodialysis or CAPD. Scand J Urol Nephrol 1984; 18: 167–72.PubMedCrossRefGoogle Scholar
  205. 205.
    Maddox Y, Foegh M, Zeligs B, Zmudka M, Bellanti J, Ramwell P. A routine source of human peritoneal macrophages. Scand J Immunol 1984; 19: 23–9.PubMedCrossRefGoogle Scholar
  206. 206.
    Cichocki T, Hanicki Z, SuLowicz W, Smolenski O, Kopec J, Zembala M. Output of peritoneal cells into peritoneal dialysate. Cytochemical and functional studies. Nephron 1983; 35: 175–82.PubMedCrossRefGoogle Scholar
  207. 207.
    Rubin J, Lin LM, Lewis R, Cruse J, Bower JD. Host defense mechanisms in continuous ambulatory peritoneal dialysis. Clin Nephrol 1983; 20: 140–4.PubMedGoogle Scholar
  208. 208.
    Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR, Elliott GR, Peterson PK. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983; 147: 1018–29.PubMedCrossRefGoogle Scholar
  209. 209.
    Lamperi S, Carozzi S. Defective opsonic activity of peritoneal effluent during continuous ambulatury peritoneal dialysis (CAPD): Importance and prevention. Perit Dial Bull 1986; 6: 87–92.Google Scholar
  210. 210.
    Struijk RG, van Ketel RJ, Krediet RT, Boeschoten EW, Arisz L. Viral peritonitis in a continuous ambulatory peritoneal dialysis patient. Nephron 1986; 44: 384.PubMedCrossRefGoogle Scholar
  211. 211.
    Goodship THJ, Heaton A, Rodger RSC. Ward MK, Wilkinson R, Kerr DNS. Factors affecting development of peritonitis in continuous ambulatory peritoneal dialysis. Br Med J 1984; 289: 1485–6.CrossRefGoogle Scholar
  212. 212.
    Goodman W, Gallagher N, Sherrard DJ. Peritoneal dialysis fluid as a source of hepatitis antigen. Nephron 1981; 29: 107–9.PubMedCrossRefGoogle Scholar
  213. 213.
    Salo RJ, Salo AA, Fahlberg WJ, Ellzey JT. Hepatitis B surface antigen (HB(s)Ag) in peritoneal fluid of HB(s) Ag carriers undergoing peritoneal dialysis. J Med Virol 1980; 6: 29–35.PubMedCrossRefGoogle Scholar
  214. 214.
    Spector D. Hepatitis B Miniepidemic in a peritoneal dialysis unit. Arch Int Med 1977; 137: 1030–1.CrossRefGoogle Scholar
  215. 215.
    Vas SI, Oreopoulos DG. Handle with care: Hepatitis B antigen carriers in peritoneal dialysis units. Nephron 1981; 29: 105–6.PubMedCrossRefGoogle Scholar
  216. 216.
    Eisenberg ES, Leviton I, Soeiro R. Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev Inf Dis 1986; 8: 309–21.CrossRefGoogle Scholar
  217. 217.
    Oh SH, Conley SB, Rose GM, Rosenblum M, Kohl S, Pickering LK. Fungal peritonitis in children undergoing peritoneal dialysis. Pediatr Inf Dis 1985; 4: 62–6.CrossRefGoogle Scholar
  218. 218.
    Vargamezis V, Papadopoulou ZL, Liamos H, Belechri AM, Natscheh T, Vergoulas G, Antoniadou R, Kilintzis V, Papadimitriou M. Management of fungal peritonitis doring continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1986; 6: 17–20.Google Scholar
  219. 219.
    Cecchin E DeMarchi S, Panarello G, Tesio F. Chemotherapy and/or removal of the peritoneal catheter in the management of fungal peritonitis complicating CAPD? Nephron 1985; 40: 251–2.PubMedCrossRefGoogle Scholar
  220. 220.
    Tapson JS, Mansy H, Freeman R, Wilkinson R. The high morbidity of CAPD fungal peritonitis-Description of 10 cases and review of treatment strategies. Quart J Med 1986; 61: 1047–53.PubMedGoogle Scholar
  221. 221.
    Kravitz SP, Berry PL. Successful treatment of Aspergillus peritonitis in a child undergoing continuous cycling peritoneal dialysis. Arch Int Med 1986; 146: 2061–2.CrossRefGoogle Scholar
  222. 222.
    Paterson AD, Bishop MC, Morgan AG, Burden RP. Removal and replacement of Tenckhoff catheter at a single operation: Successful treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1986; 2: 1245–7.PubMedCrossRefGoogle Scholar
  223. 223.
    Craddock CF, Edwards R, Finch RG. Pseudomonas peritonitis in continuous ambulatory peritoneal dialysis: laboratory predictors of treatment failure. J Hosp Infec 10: 179–86.Google Scholar
  224. 224.
    West TE, Walshe JJ, Krol CP, Amsterdam D. Staphylococcal peritonitis in continuous peritoneal dialysis. J Clin Microbiol 1986; 23: 809–12.PubMedGoogle Scholar
  225. 225.
    Peterson PK, Lee D, Suh HJ, Devalon M, Nelson RD, Keane WF. Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis 1986; 7: 146–52.PubMedGoogle Scholar
  226. 226.
    Piraino B, Bernardini J, Sorkin M, The influence of peritoneal catheter exit site infections on peritonitis, tunnel infections and catheter loss in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1986; 8: 435–40.Google Scholar
  227. 227.
    Beasley SW, Meech PR, Neale TJ, Hatfield PJ, Morrison RB. Continuous ambulatory peritoneal dialysis and acute appendicitis. NZ Med J 1986; 99: 145–6.Google Scholar
  228. 228.
    Spence PA, Mathews RE, Khanna R, Oreopoulos DG. Indications for operation when peritonitis ocurs in patients on chronic ambulatory peritoneal dialysis. Surg Gynecol Obstet 1985; 161: 450–2.PubMedGoogle Scholar
  229. 229.
    Lempert KD, Kolb JA, Swartz RD, Campese V, Golper TA, Winchester JF, Bolph KD, Husserl FE, Zimmerman SW, Kurtz SB. A multicenter trial to evaluate the use of the CAPD “O” set. ASAIO Trans 1986; 32: 557–9.PubMedCrossRefGoogle Scholar
  230. 230.
    Holmes CJ, Miyake C, Kubey W. In vitro evaluation of an ultraviolet germicidal connection system for CAPD. Perit Dial Bull 1984; 3: 215–8.Google Scholar
  231. 231.
    Nolph KD. Randomized multicenter clinical trial to evaluate the effects of an ultraviolet germicidal system on peritonitis rates in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1985; 19–24.Google Scholar
  232. 232.
    Hamilton RW, Disher BA, Dillingham SA, Nicholas AF. The sterile weld: A new method for connections in continuous ambulatory peritoneal dialysis. Perit Dial Bull 1983; 3 (suppl. 4): 8–10.Google Scholar
  233. 233.
    LaRocco MT, Mortensen JE, Robinson A. Mycobacterium fortuitum peritonitis in a patient undergoing chronic peritoneal dialysis. Diagn Microbiol Infect Dis 1986; 4: 161–4.PubMedCrossRefGoogle Scholar
  234. 234.
    Eisenberg ES, Ambalu M, Szylagi G, Aning V, Soeiro R. Colonization of skin and development of peritonitis due to coagulase negative staphylococci in patients undergoing peritoneal dialysis. J Inf Dis 1987; 156: 478–82.CrossRefGoogle Scholar
  235. 235.
    VI. Catheter related factors and peritonitis risk in CAPD patients. USRDS 1992 Annual Report. Am J Kidney Dis 20 (suppl. 2): 48–54.Google Scholar
  236. 236.
    Port FK, Held PJ, Nolph kd, Truenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connectin technique: A national study. Kidney Int 1992; 42: 967–74.PubMedCrossRefGoogle Scholar
  237. 237.
    Scalamogna A, Castelnovo c, DeVecchi A, Ponticelli C. Exit-site and tunnel infections in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1992; 18: 674–7.Google Scholar
  238. 238.
    Holley JL, Bernardini J, Pirano B. Risk factors for tunnel infections in continous peritoneal dialysis. Am J Kidney Dis 1992; 18: 344–52.Google Scholar
  239. 239.
    Peterson PK, Matzke GR, Keane WF. Current concepts in the management of peritonitis in continuous ambulatory peritoneal dialysis patients. Rev Infec Dis: 9: 604–12.Google Scholar
  240. 240.
    Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11: 252–60.PubMedGoogle Scholar
  241. 241.
    Von Graevenitz A, Amsterdam D. Microbiological aspects of peritonitis associated with continuous ambulatory peritoneal dialysis. Clin Microbiol Rev 1992; 5: 26–48.Google Scholar
  242. 242.
    Gilbert DB. Once -daily aminoglycoside therapy. Antimicrob Agents Chemother 1991; 35: 399–405.PubMedCrossRefGoogle Scholar
  243. 243.
    Nordstrom L, Lerner SA. Single daily dose therapy with aminoglycosides. J. Hosp Inf 1991; 18 (suppl A): 117–29.CrossRefGoogle Scholar
  244. 244.
    Levison ME. New dosing regimens for aminoglycoside antibiotics. Ann Int Med 1992; 117: 693–4.PubMedGoogle Scholar
  245. 245.
    Parker, SE, Davey PG. Once daily aminoglycoside dosing. Lancet 1993; 341: 346–7.PubMedCrossRefGoogle Scholar
  246. 246.
    Odenholt-Tornquist I, Lowdin E, Cars O. Postantibiotic sub-MIC Effects of Vancomycin, Roxithromycin, Sparfloxin and Amikacin. Antimicrob Chemother 1992; 36: 1852–8.CrossRefGoogle Scholar
  247. 247.
    Lewis S, Holmes C. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Part 1 Perit Dial Int 1992; 11: 14–21.Google Scholar
  248. 248.
    Holmes C, Lewis S. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Part 2 Perit Dial Int 1992; 11: 112–7.Google Scholar
  249. 249.
    Digenis G, Abraham G, Savin E, Blake P, Dombros N., Sombolos K, Vas S, Matthews R, Oreopoulos DG. Peritonitis related deaths in continouos ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 1990; 10: 45–7.PubMedGoogle Scholar
  250. 250.
    Johnson CA. Intraperitoneal vancomycin administration. Perit Dial Int 1991; 11: 9–11.PubMedGoogle Scholar
  251. 251.
    Freiman JP, Graham DJ, Reed TG, McGoodwin EB. Chemical Peritonitis following the intraperitoneal administration of vancomycin. Perit Dial Int 1992; 12: 57–60.PubMedGoogle Scholar
  252. 252.
    Magera BE, Arroyo JC, Rosansky SJ, Postic B. Vancomycin pharmacokinetics in patients with peritonitis on peritoneal dialysis. Antimicrob Agents Dhemother 1983; 23: 710–4.CrossRefGoogle Scholar
  253. 253.
    Harford AM, Sica DA, Tartaglione T, Polk RE,Dalton HP, Poynor W. Vancomycin pharmacokinetics in continouous ambulatory peritoneal dialysis patients with peritonitis. Nephron 1986; 43: 217–22.PubMedCrossRefGoogle Scholar
  254. 254.
    Bastani B. Freer K, Read D, Bailey S, Sherman RA, Davis M, Engels D. Treatment of gram positive peritonitis with two intraperitoneal doses of vancomycin in continuous ambulatory peritoneal dialysis patients. Nephron 1987: 45: 283–5.PubMedCrossRefGoogle Scholar
  255. 255.
    Boyce NW, Wood C, Thomson NM, Kerr P, Atkins RC. Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis-a prospective randomized comparison of intermittent v continuous therapy. Am J Kidney Dis 1988; 12: 304–6.PubMedGoogle Scholar
  256. 256.
    Brown J, Altman P, Cunningham of J Chaw E, Marsk F. Pharmacokinetics of once daily intraperitoneal aztreonam and vancomycin in the treatment of CAPD peritonitis. J Antimicr Chemother 1990; 25: 141–7.CrossRefGoogle Scholar
  257. 257.
    Fellin G, Gentile MG, Manna GM et al. Peritonitis prevention: Y connector and sodium hypochlorite. Three years’ experience. Report of the Italian study group. In: Khanna R. Nolph KD, Prowant B, Twardowski ZJ, Oreopoulos DG (eds), Advances in Peritoneal Dialysis. Perit Dial Int Inc. Toronto 1987; 3: 114–8.Google Scholar
  258. 258.
    Canadian CAPD Clinical Trials Group. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multi-center randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989; 9: 159–63.Google Scholar
  259. 259.
    Viglino G, Cancarini G, Catizone L, Cocchi R, de Vecchi A, Lupo A, Salomone M, Segoloni GP, Giangrande A. The impact of peritonitis on CAPD results. In: Khanna R, Nolph DK 1992; Prowant B, Twardowski ZJ, Oreopoulos DG (eds), Advances in Peritonal Dialysis Perit Dial Int Inc, Toronto 1992; 8: 270–5.Google Scholar
  260. 260.
    Twardowski ZJ, Dobbie JW, Moore HL, Nichols WK, De Spain JD, Anderson PC, Khanna R, Nolph KD, Loy TS. Morphology of peritoneal dialysis catheter tunnel. I, Macroscopy and light microscopy. Perit Dial Int 1991; 11: 237–51.PubMedGoogle Scholar
  261. 261.
    Chong TK, Piraino B, Bernardini J. Vestibular toxicity due to gentamicin in peritoneal dialysis patients. Perit Dial Int 1991; 11: 152–5.PubMedGoogle Scholar
  262. 262.
    Nikolaidis P, Vas S, Lawson V, Kennedy-Vosu L, Bernard A, Abraham G, Izatt S, Khanna S, Bargman JM, Oreopoulos DG. Is intraperitoneal tobramycin ototoxic in CAPD patients? Perit Dial Int 1991; 11: 156–61.PubMedGoogle Scholar
  263. 263.
    Vonesh EF. Which statistical method to use when analyzing the incidence of peritoneal dialysis related inmfections. Perit Dial Int 1991; 11: 301–4.PubMedGoogle Scholar
  264. 264.
    Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14–27.PubMedGoogle Scholar
  265. 265.
    Breborowicz A. Free radicals in peritoneal dialysis: agents of damage. Perit Dial Int 1992; 12: 194–8.PubMedGoogle Scholar
  266. 266.
    Dasgupta MK, Fox S, Gagnon D, Bettcher K, Ulan RA. Significant reduction of peritonitis rate by the use of twin-bag system in a Canadian regional CAPD program. In: Khanna R, Nolph KD, Prowant B, Twardowski ZJ, Oreopoulos DG (eds), Advances in Peritoneal Dialysis. Perit Dial Int Inc, Toronto 1992; 8: 223–6.Google Scholar
  267. 267.
    Hutchison A, Gokal R. Peritoneal dialysis fluids for the future: Do we have the solution? Dialysis Transplant. 1992; 12: 199–203.Google Scholar
  268. 268.
    Ing TS, Zhou XJ, Yu AW, Vazir ND. Lactate-containing versus bicarbonate-containing peritoneal dialysis solutions. Perit Dial Int 1992; 12: 276–7.PubMedGoogle Scholar
  269. 269.
    Oreopoulos DG. Peritoneal dialysis research for the 1990’s. Perit Dial Int 1992; 12: 278–80.PubMedGoogle Scholar
  270. 270.
    Vas SI. Primary and secondary role of viruses in chronic renal failure. Kidney Intrnational 1991; 40 (suppl 35): 2–4.Google Scholar
  271. 271.
    Prowant BF, Warady BA, Nolph KD. Peritoneal dialysis exit site care: Results of an international survey. Perit Dial Int 1993; 13: 149–54.PubMedGoogle Scholar
  272. 272.
    Korbet SM, Vonesh EF, Firanek CA. A retro spective assessment of risk factors for peritonitis among an urban CAPD population. Perit Dial Int 1993; 13: 126–31.PubMedGoogle Scholar
  273. 273.
    Maiorca R, Cantalupppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, Brasa S, Ponticelli C (1989) Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Lancet 1983; 2: 642–4.PubMedCrossRefGoogle Scholar
  274. 274.
    Gokal R, Ramos M, Francis D et al. Peritonitis in CAPD. Lancet 1982; 2: 1388–91.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1994

Authors and Affiliations

  • William F. Keane
  • Stephen I. Vas

There are no affiliations available

Personalised recommendations